RxDoctor Payments Data

Jennifer Ramirez, PA

Physician Assistant · Gilbert, AZNPI 1023484201

Payments from drug & device makers

$691in general payments, 2019–2025

Across 35 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$121
  • AbbVie$116
  • Idorsia Pharmaceuticals US Inc$70
  • Teva Pharmaceuticals USA, Inc.$67
  • Vanda Pharmaceuticals Inc.$51
  • Brainsway USA Inc$39
  • plus $227 from 10 others

What the payments were for

  • Food & beverage$68399%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$691 in reported general payments places this provider in the 60th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$30,105
Medicare patients
42
Services billed
360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate29$246,828
RexultiBrexpiprazole16$27,345
Lurasidone Hcl69$13,180
BelsomraSuvorexant24$10,603
Olanzapine32$8,679
Aripiprazole93$8,039
Vilazodone Hcl41$6,912
QuviviqDaridorexant Hcl11$5,347
Desvenlafaxine Succinate ErDesvenlafaxine Succinate36$4,196
Divalproex Sodium30$3,746
Duloxetine Hcl83$3,449
Trazodone Hcl113$3,175
Lisdexamfetamine Dimesylate15$3,023
Hydroxyzine Hcl63$2,416
Quetiapine Fumarate84$2,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$20$246,82829 claims
Idorsia Pharmaceuticals US IncQuviviq$70$5,34711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →